EGFR and breast cancer: miR-451 induction inhibited EGFR, HER2, and mitogen-activated protein kinase (MAPK) signaling and enhanced apoptosis in TAM-resistant BC lines, suggesting that miR-451 may have therapeutic potential for ER-positive BC [80].